Jurickson Profar’s MLB Season-Long Ban Casts Shadow Over Atlanta Braves’ 2026 Campaign
Atlanta Braves’ star Jurickson Profar is set to miss the entirety of the 2026 Major League Baseball season, a significant blow to the team’s aspirations. This comes after his appeal against a positive test for performance-enhancing drugs (PEDs) was reportedly denied. The ban means Profar, 33, will serve a full 162-game suspension, marking his second career violation and leading to the forfeiture of his entire $15 million salary for the 2026 season.
The news, as reported by ESPN’s Jeff Passan, also confirms Profar’s ineligibility for any postseason play in 2026. This latest development follows a previous 80-game suspension without pay last year after he tested positive for Chorionic Gonadotrophin (hCG). Profar now joins an exclusive and unfortunate group, becoming only the sixth player in MLB history to receive a 162-game ban for PED use. This increased penalty for repeat offenders was instituted by Major League Baseball in 2024.
Profar’s journey to this point has been a notable one. He achieved All-Star status with the San Diego Padres in 2024. Shortly after, in January 2025, he signed a lucrative $42 million contract with the Braves, a move that preceded his initial ban by just two months.
Following his first suspension last year, Profar publicly stated his commitment to the integrity of the game, saying, “it is because of my deep love and respect for this game that I would never knowingly do anything to cheat it.” The Atlanta Braves organisation expressed their sentiment at the time, calling the news “surprising and extremely disappointing” while also affirming their “full support” for the league’s drug program and their hope that Profar would “learn from this experience.”
The absence of Profar for the entire 2026 season presents a considerable challenge for the Braves. This is compounded by existing concerns over starting pitchers Spencer Schwellenbach and Hurston Waldrep, both of whom are sidelined due to elbow injuries. Last season, Profar made a return to the team in July, making his debut and contributing offensively with a .245 batting average, .353 on-base percentage, and .434 slugging percentage, including 14 home runs.
A Promising Career Marred by Suspensions
Profar’s career began with significant promise. He was once regarded as the number one prospect in baseball, making his debut at the young age of 19 with the Texas Rangers. However, his early career was also marked by periods spent on the injury report. This past offseason, he underwent surgery for a sports hernia. Prior to this latest suspension, he was slated to transition to a designated hitter role and was expected to bat near the top of the Braves’ lineup for the upcoming season.
Manager Walt Weiss will now face the unenviable task of reconfiguring his strategic plans for 2026. Profar’s unavailability for the entire campaign necessitates a significant adjustment to the team’s roster and game strategy.
When Profar becomes eligible to return to play in the 2027 season, he will have one year remaining on his contract. He is slated to earn another $15 million in that final year. The implications of his extended absence extend beyond the immediate 2026 season, raising questions about his future impact and the Braves’ long-term planning. The team will need to navigate this period without one of their key offensive players, relying on other members of the roster to step up and fill the void left by his significant suspension. The league’s commitment to a clean game, underscored by such stringent penalties for repeat offenders, continues to shape the landscape of professional baseball.
